Nath Bio-Genes

  • Market Cap: Micro Cap
  • Industry: Other Agricultural Products
  • ISIN: INE448G01010
  • NSEID: NATHBIOGEN
  • BSEID: 537291
INR
145.35
2.15 (1.5%)
BSENSE

Jan 30

BSE+NSE Vol: 15.2 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Net Sales
393.51
312.94
289.59
256.38
Other Operating Income
0.00
0.00
0.00
0.00
Total Operating income
393.51
312.94
289.59
256.38
Raw Material Cost
0.00
0.00
0.00
0.00
Purchase of Finished goods
5.65
11.78
8.54
6.22
(Increase) / Decrease In Stocks
-56.92
-17.85
49.13
30.30
Employee Cost
31.59
26.16
21.08
17.20
Power Cost
0.00
0.00
0.00
0.00
Manufacturing Expenses
236.98
153.94
83.46
81.43
Selling and Distribution Expenses
103.77
75.74
66.43
63.07
Other Expenses
24.47
13.78
13.51
13.35
Total Expenditure (Excl Depreciation)
345.54
263.55
242.15
211.57
Operating Profit (PBDIT) excl Other Income
47.97
49.39
47.44
44.81
Other Income
5.44
0.69
0.22
0.30
Operating Profit (PBDIT)
53.41
50.08
47.66
45.11
Interest
11.39
9.12
8.04
8.59
Exceptional Items
4.75
0.00
0.00
0.00
Gross Profit (PBDT)
46.77
40.96
39.62
36.52
Depreciation
2.94
2.48
2.28
2.02
Profit Before Tax
43.82
38.48
37.34
34.49
Tax
2.17
1.36
1.34
0.93
Provisions and contingencies
0.00
0.00
0.00
0.00
Profit After Tax
41.63
37.12
36.00
33.58
Extraordinary Items
0.00
0.00
2.50
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
Net Profit
41.63
37.12
38.50
33.58
Share in Profit of Associates
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.02
0.00
Other related items
0.00
0.00
0.00
0.00
Consolidated Net Profit
41.63
37.12
38.54
33.58
Equity Capital
19.00
19.00
19.00
19.00
Face Value
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
588.93
556.54
Diluted Earnings per share
0.84
1.33
2.02
0.71
Operating Profit Margin (Excl OI)
12.19%
15.78%
16.38%
17.48%
Gross Profit Margin
11.89%
13.09%
13.68%
14.24%
PAT Margin
10.58%
11.86%
12.43%
13.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 25.75% vs 8.06% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 12.15% vs -3.68% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is -2.88% vs 4.11% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 24.89% vs 13.43% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Nath Bio-Genes With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
393.51
76.80
316.71
412.38%
Other Operating Income
0.00
0.00
0.00
Total Operating income
393.51
76.80
316.71
412.38%
Raw Material Cost
0.00
0.00
0.00
Purchase of Finished goods
5.65
39.14
-33.49
-85.56%
(Increase) / Decrease In Stocks
-56.92
19.43
-76.35
-392.95%
Employee Cost
31.59
10.16
21.43
210.93%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
236.98
0.00
236.98
Selling and Distribution Expenses
103.77
0.00
103.77
Other Expenses
24.47
11.71
12.76
108.97%
Total Expenditure (Excl Depreciation)
345.54
80.44
265.10
329.56%
Operating Profit (PBDIT) excl Other Income
47.97
-3.64
51.61
1,417.86%
Other Income
5.44
0.71
4.73
666.20%
Operating Profit (PBDIT)
53.41
-2.93
56.34
1,922.87%
Interest
11.39
1.18
10.21
865.25%
Exceptional Items
4.75
0.00
4.75
Gross Profit (PBDT)
46.77
-4.11
50.88
1,237.96%
Depreciation
2.94
0.75
2.19
292.00%
Profit Before Tax
43.82
-4.86
48.68
1,001.65%
Tax
2.17
-1.15
3.32
288.70%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
41.63
-3.71
45.34
1,222.10%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
41.63
-3.71
45.34
1,222.10%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
41.63
-3.71
45.34
1,222.10%
Equity Capital
19.00
65.59
-46.59
-71.03%
Face Value
10.00
10.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
11.89%
-5.35%
0.00
17.24%
PAT Margin
10.58%
-4.83%
0.00
15.41%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 393.51 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 25.75% vs 8.06% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 41.63 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 12.15% vs -3.68% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.97 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -2.88% vs 4.11% in Dec 2024

Nine Monthly - Interest
Interest 11.39 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 24.89% vs 13.43% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 12.19%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024